Can hyperthermic intrathoracic perfusion chemotherapy added to lung sparing surgery be the solution for malignant pleural mesothelioma?


Isik A. F. , Sanli M., Dikensoy Ö. , Aytekin I., Benli Y., Sevinc A., et al.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, cilt.24, ss.325-332, 2016 (SCI İndekslerine Giren Dergi)

  • Cilt numarası: 24 Konu: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.5606/tgkdc.dergisi.2016.11798
  • Dergi Adı: TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
  • Sayfa Sayısı: ss.325-332

Özet

Background: This study aims to investigate whether hyperthermic intrathoracic perfusion chemotherapy added to lung sparing cytoreductive surgery is superior to extrapleural pneumonectomy in patients with malignant pleural mesothelioma in terms of survival.